NN9536-4937 Wegovy® (semaglutide 2.4 mg) Pregnancy Registry Study: A Prospective Cohort Study to Investigate Safety Outcomes of Exposure to Wegovy during Pregnancy

10/05/2023
14/03/2024
EU PAS number:
EUPAS104613
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

4937 16-1-01 protocol eu-pas-reg redacted

English (1.4 MB - PDF) View document
Study results
Study report
Other information